Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
ATAIBECKLEY INC. Secures Approval for Merger
PUBLIC · ATAISep 08, 2026•about 3 hours ago
Acquiring Company
AtaiBeckley
Acquired Company
Not specified
United StatesBiotechnologyHealth CareTherapeuticsLocal Business
Description
AtaiBeckley Inc. held a special meeting to vote on proposals related to a merger agreement. The meeting concluded with 65.6% of stockholder shares represented. Relevant documents were submitted to the SEC prior to the meeting.
Company Information
Company
AtaiBeckley
Location
United States
About
AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. The company specializes in psychedelic and non-psychedelic compounds, aiming to innovate treatment options for conditions such as depression, anxiety, and addiction. AtaiBeckley Inc. operates in the healthcare industry and is dedicated to scientific research and collaboration, engaging in partnerships with various organizations and institutions. The company is registered under the ticker symbol ATAI on the Nasdaq Global Market, indicating a significant operational scale and commitment to public accountability. Recent developments suggest an ongoing emphasis on advancing clinical trials for its key product pipeline.
Don't miss AtaiBeckley's next move
Get an email the moment AtaiBeckley makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Predictive Intelligence
Strategic
ML-powered predictions for AtaiBeckley's next move
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed
Frequently asked
Who acquired Not specified?
Not specified was acquired by AtaiBeckley, based in United States. The deal was reported on September 8, 2026. AtaiBeckley Inc. is a biotechnology company based in Delaware, primarily focused on the development of novel therapeutics for mental health disorders. AtaiBeckley is publicly traded (ATAI) and operates in Biotechnology.
When did AtaiBeckley acquire Not specified?
AtaiBeckley's acquisition of Not specified was reported on September 8, 2026. AtaiBeckley Inc. held a special meeting to vote on proposals related to a merger agreement. The meeting concluded with 65.6% of stockholder shares represented. Relevant documents were submitted to the SEC prior to the meeting. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Not specified do?
Not specified It is privately held, operating in Local Business.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
United StatesBiotechnologyHealth CareTherapeuticsLocal Business